Example #1: Jack B. Evans, Chair, Judith M. Stockdale and Terence J. Toth are current members of the dividend committee of each Fund.
Expected output: 'entities: [{'span': 'Jack B. Evans', 'entity': 'Person'}, {'span': 'Judith M. Stockdale', 'entity': 'Person'}, {'span': 'Terence J. Toth', 'entity': 'Person'}]'

Example #2: Robert P. Bremner, Jack B. Evans, David J. Kundert, Chair, William J. Schneider and Terence J. Toth are current members of the audit committee of each Fund.
Expected output: 'entities: [{'span': 'Robert P. Bremner', 'entity': 'Person'}, {'span': 'Jack B. Evans', 'entity': 'Person'}, {'span': 'David J. Kundert', 'entity': 'Person'}, {'span': 'William J. Schneider', 'entity': 'Person'}, {'span': 'Terence J. Toth', 'entity': 'Person'}]'

Example #3: Robert P. Bremner, Chair, Jack B. Evans, William C. Hunter, David J. Kundert, William J. Schneider, Judith M. Stockdale, Carole E. Stone and Terence J. Toth are current members of the nominating and governance committee of each Fund.
Expected output: 'entities: [{'span': 'Robert P. Bremner', 'entity': 'Person'}, {'span': 'Jack B. Evans', 'entity': 'Person'}, {'span': 'William C. Hunter', 'entity': 'Person'}, {'span': 'David J. Kundert', 'entity': 'Person'}, {'span': 'William J. Schneider', 'entity': 'Person'}, {'span': 'Judith M. Stockdale', 'entity': 'Person'}, {'span': 'Carole E. Stone', 'entity': 'Person'}, {'span': 'Terence J. Toth', 'entity': 'Person'}]'

Example #4: Board Members Amboian, Kundert and Toth were last elected to each Fund s Board as Class II Board Members and Board Member Hunter was last elected to each Fund s Board as a Class I Board Member at the annual meeting of shareholders held on June 30, 2008.
Expected output: 'entities: [{'span': 'Amboian', 'entity': 'Person'}, {'span': 'Kundert', 'entity': 'Person'}, {'span': 'Toth', 'entity': 'Person'}, {'span': 'Hunter', 'entity': 'Person'}]'

Example #5: This Information Statement has been filed with the Securities and Exchange Commission and is being furnished, pursuant to Section 14C of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), to the holders (the “ Stockholders ”) of the common stock, par value $ .0001 per share (the “ Common Stock ”), of Comcam, Inc., a Delaware Corporation (the “ Company ”), to notify such Stockholders that on or about March 5, 2010, the Company received written consents in lieu of a meeting of Stockholders from holders of 683,952,500 shares representing approximately 91 % of the 744,640,134 shares of the total issued and outstanding shares of voting stock of the Company (the “ Majority Stockholders ”) to authorize 1-for-85 reverse stock split (pro-rata reduction of outstanding shares) of our issued and outstanding shares of Common Stock (the “ Reverse Stock Split ”).
Expected output: 'entities: [{'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': 'Exchange Act', 'entity': 'Legislation/Act'}, {'span': 'Comcam, Inc.', 'entity': 'Business'}, {'span': 'Delaware', 'entity': 'Location'}]'

Example #6: The Corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment in its favor by reason of the fact that such person is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys ’ fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the Corporation unless and only to the extent that the Court of Chancery of the State of Delaware or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability, but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.
Expected output: 'entities: [{'span': 'Court of Chancery of the State of Delaware', 'entity': 'Court'}, {'span': 'Court of Chancery', 'entity': 'Court'}]'

Example #7: Premium was September 30, 2009.
Expected output: 'entities: []'

Example #8: The number of regular quarterly meetings and special meetings held by the Board of each Fund during the Fund s last fiscal year is shown in Appendix C. During the last fiscal year, each Board Member attended 75 % or more of each Fund s Board meetings and the committee meetings (if a member thereof) held during the period for which such Board Member was a Board Member.
Expected output: 'entities: []'

Example #9: On October 31, 2003, the New York District Court entered a Final Judgment As To Defendant JPMSI (the “ JPMSI Research Analysts Final Judgment ”) that, among other things, enjoined JPMSI, directly or through its officers, directors, agents and employees, from violating then NASD Conduct Rules 2110, 2210, and 3010 and NYSE Rules 342, 401, 472, and 476 (the “ JPMSI Research Analysts Injunction ”).
Expected output: 'entities: [{'span': 'New York District Court', 'entity': 'Court'}, {'span': 'JPMSI', 'entity': 'Business'}, {'span': 'JPMSI Research Analysts Final Judgment', 'entity': 'Miscellaneous'}, {'span': 'NASD Conduct Rules', 'entity': 'Legislation/Act'}, {'span': 'NYSE Rules', 'entity': 'Legislation/Act'}, {'span': 'JPMSI Research Analysts Injunction', 'entity': 'Miscellaneous'}]'

Example #10: The inspectors of election will treat abstentions and broker non-votes (i.e., shares held by brokers or nominees, typically in street name, as to which (i) instructions have not been received from the beneficial owners or persons entitled to vote and (ii) the broker or nominee does not have discretionary voting power on a particular matter) as present for purposes of determining a quorum.
Expected output: 'entities: []'

Example #11: In considering a candidate s qualifications, each candidate must meet certain basic requirements, including relevant skills and experience, time availability and, if qualifying as an Independent Board Member candidate, independence from the Adviser or other service providers.
Expected output: 'entities: []'

Example #12: Investors may obtain a free copy of the proxy statement, as well as other filings containing information about Chemical Financial and OAK, free of charge from the SEC's website (www.sec.gov); by contacting Chemical Financial Corporation, 333 East Main Street, PO Box 569, Midland, MI 48640-0569, Attention: Ms. Lori A. Gwizdala, Investor Relations, telephone 800-867-9757 or by contacting O.A.K. Financial Corporation, 2445 84th Street, SW, Byron Center, MI 49315, Attention: Mr. James A. Luyk, Investor Relations, telephone 616-599-7419.
Expected output: 'entities: [{'span': 'Chemical Financial', 'entity': 'Business'}, {'span': 'OAK', 'entity': 'Business'}, {'span': 'SEC', 'entity': 'Government'}, {'span': 'Chemical Financial Corporation', 'entity': 'Business'}, {'span': 'East Main Street', 'entity': 'Location'}, {'span': 'Midland', 'entity': 'Location'}, {'span': 'MI', 'entity': 'Location'}, {'span': 'Lori A. Gwizdala', 'entity': 'Person'}, {'span': 'O.A.K. Financial Corporation', 'entity': 'Business'}, {'span': '84th Street, SW', 'entity': 'Location'}, {'span': 'Byron Center', 'entity': 'Location'}, {'span': 'James A. Luyk', 'entity': 'Person'}]'

Example #13: We, the undersigned directors of Acorda Therapeutics, Inc., hereby severally constitute and appoint Ron Cohen our true and lawful attorney with full power to him to sign for us and in our names in the capacities indicated below, this Registration Statement on Form S-8 filed herewith and any and all subsequent amendments to said registration statement, and generally to do all such things in our names and on our behalf in our capacities as directors to enable Acorda Therapeutics, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorney to said registration statement and any and all amendments thereto.
Expected output: 'entities: [{'span': 'Acorda Therapeutics, Inc.', 'entity': 'Business'}, {'span': 'Ron Cohen', 'entity': 'Person'}, {'span': 'Form S-8', 'entity': 'Miscellaneous'}, {'span': 'Securities Act of 1933', 'entity': 'Legislation/Act'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #14: Morgan Securities executed on June 17, 2011, a Consent of Defendant J.P. Morgan Securities (the “ Consent ”), in which J.P. Morgan Securities neither admitted nor denied any of the allegations (except as to personal and subject matter jurisdiction) in a complaint filed by the Commission, but in which it consented to the entry of a final judgment (“ Final Judgment ”) against it by the United States District Court for the Southern District of New York (the “ Court ”).
Expected output: 'entities: [{'span': 'Morgan Securities', 'entity': 'Business'}, {'span': 'J.P. Morgan Securities', 'entity': 'Business'}, {'span': 'United States District Court for the Southern District of New York', 'entity': 'Court'}]'

Example #15: For each other Massachusetts Business Trust except New York Value 2, Core Equity, Equity Premium, Equity Premium Advantage, Equity Premium Income, Equity Premium Opportunity, Global Government, Global Value, Tax-Advantaged Dividend and Multi-Currency, New York Dividend, New York Dividend 2, Insured New York Dividend and Insured New York Tax-Free, Board Members Amboian, Kundert and Toth were last elected to each Fund s Board as Class II Board Members at the annual meeting of shareholders held on June 30, 2008.
Expected output: 'entities: [{'span': 'Massachusetts', 'entity': 'Location'}, {'span': 'New York Value 2', 'entity': 'Business'}, {'span': 'Core Equity', 'entity': 'Business'}, {'span': 'Equity Premium', 'entity': 'Business'}, {'span': 'Equity Premium Advantage', 'entity': 'Business'}, {'span': 'Equity Premium Income', 'entity': 'Business'}, {'span': 'Equity Premium Opportunity', 'entity': 'Business'}, {'span': 'Global Government', 'entity': 'Business'}, {'span': 'Global Value', 'entity': 'Business'}, {'span': 'Tax-Advantaged Dividend', 'entity': 'Business'}, {'span': 'Multi-Currency', 'entity': 'Business'}, {'span': 'New York Dividend', 'entity': 'Business'}, {'span': 'New York Dividend 2', 'entity': 'Business'}, {'span': 'Insured New York Dividend', 'entity': 'Business'}, {'span': 'Insured New York Tax-Free', 'entity': 'Business'}, {'span': 'Amboian', 'entity': 'Person'}, {'span': 'Kundert', 'entity': 'Person'}, {'span': 'Toth', 'entity': 'Person'}]'

Example #16: IPOs On October 1, 2003, the Commission filed a complaint (the “ IPO Complaint ”) against J.P. Morgan Securities Inc. (predecessor to JPMS, “ JPMSI ”) in the United States District Court for the District of Columbia (the “ D.C. District Court ”) in a civil action captioned Securities and Exchange Commission v. J.P. Morgan Securities Inc..
Expected output: 'entities: [{'span': 'IPO Complaint', 'entity': 'Miscellaneous'}, {'span': 'J.P. Morgan Securities Inc.', 'entity': 'Business'}, {'span': 'JPMS', 'entity': 'Business'}, {'span': 'JPMSI', 'entity': 'Business'}, {'span': 'United States District Court for the District of Columbia', 'entity': 'Court'}, {'span': 'D.C. District Court', 'entity': 'Court'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #17: To be considered for presentation at the annual meeting of shareholders for the Funds to be held in 2011, shareholder proposals submitted pursuant to Rule 14a-8 of the 1934 Act must be received at the offices of that Fund, 333 West Wacker Drive, Chicago, Illinois 60606, not later than January 4, 2011.
Expected output: 'entities: [{'span': '1934 Act', 'entity': 'Legislation/Act'}, {'span': 'West Wacker Drive', 'entity': 'Location'}, {'span': 'Chicago', 'entity': 'Location'}, {'span': 'Illinois', 'entity': 'Location'}]'

Example #18: If a communication does not indicate a specific Board Member, it will be sent to the Independent Chairman and the outside counsel to the Independent Board Members for further distribution as deemed appropriate by such persons.
Expected output: 'entities: []'

Example #19: The nominating and governance committee looks to many sources for recommendations of qualified candidates, including current Board Members, employees of the Adviser, current shareholders of the Funds, third party sources and any other persons or entities that may be deemed necessary or desirable by the committee.
Expected output: 'entities: []'

Example #20: The following tables provide the aggregate fees billed during each Fund s last two fiscal years by each Fund s independent registered public accounting firm for engagements directly related to the operations and financial reporting of each Fund including those relating (i) to each Fund for services provided to the Fund and (ii) to the Adviser and certain entities controlling, controlled by, or under common control with the Adviser that provide ongoing services to each Fund (Adviser Entities).
Expected output: 'entities: []'

